Research chemical

Torkinib

CAS Number: 1092351-67-1

Torkinib molecular structure, CAS 1092351-67-1 — Chemical structure

Product details

Identity & specification

Molecular formula: C16H16N6O
Molecular weight: 308.34 g/mol
Product type: Research-use catalog compound
Documentation: COA / SDS available by request

For laboratory research and professional procurement workflows.

Technical identifiers

Show PubChem, InChIKey, IUPAC, and SMILES

PubChem CID

135565635

Exact Mass

308.138559

InChIKey

MFAQYJIYDMLAIM-UHFFFAOYSA-N

IUPAC Name

2-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol

SMILES String

CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21

Physical Properties

Appearance

White to yellow or pale-brown powder or crystals

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Computed Structure Descriptors

Show calculated structure fields

Heavy atom count

23

H-bond acceptors

7

H-bond donors

4

Rotatable bonds

2

Ring count

4

Aromatic rings

4

Topological polar surface area

105.64 Å²

Computed LogP

2.84

Fragment-like structure rule

No

Lead-like structure rule

No

Drug-like structure rule

Yes

Structure family

n heterocycle ligand

Precious metal motif

No

Transition metal motif

No

Phosphine ligand motif

No

N-heterocycle motif

Yes

Boronic acid motif

No

Computed structure descriptors generated from molecular structure. These are not experimental physical property values, supplier specifications, SDS data, or bioactivity claims.

Catalog Facts

Structural features

Torkinib (CAS 1092351-67-1) is maintained as a cataloged research chemical with formula C16H16N6O, molecular weight 308. 34 g/mol, PubChem CID 135565635.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Use this page for identity verification, package-aware sourcing review, and RFQ preparation; structure-derived tags include nitrogen-containing heterocycle, drug-like rule profile.

Documentation needs

SDS signal word: Warning; hazard codes: H302, H315, H319, H335; for research use only.

Applications & Classification

Package and Price Reference Supplier Catalog Sourcing Commercial Research Chemicals Heterocyclic Building BlocksResearch intermediateCustom synthesis building blockResearch chemical sourcingCustom synthesis and catalog availability review

Biological target reference

ChEMBL reports experimental activity evidence for: Serine/threonine-protein kinase mTOR (Homo sapiens) — 16 assays; Proto-oncogene tyrosine-protein kinase receptor Ret (Homo sapiens) — 7 assays; mTORC1 (Homo sapiens) — 4 assays; Protein kinase C epsilon type (Homo sapiens) — 2 assays; Tyrosine-protein kinase JAK2 (Homo sapiens) — 4 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Serine/threonine-protein kinase mTOR

Homo sapiens · SINGLE PROTEIN · 16 qualifying assays · 11 documents · best pChEMBL 8.52

Experimental evidence source: ChEMBL

Proto-oncogene tyrosine-protein kinase receptor Ret

Homo sapiens · SINGLE PROTEIN · 7 qualifying assays · 2 documents · best pChEMBL 8.4

Experimental evidence source: ChEMBL

mTORC1

Homo sapiens · PROTEIN COMPLEX · 4 qualifying assays · 3 documents · best pChEMBL 8.1

Experimental evidence source: ChEMBL

Protein kinase C epsilon type

Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 2 documents · best pChEMBL 8.05

Experimental evidence source: ChEMBL

Tyrosine-protein kinase JAK2

Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 2 documents · best pChEMBL 7.96

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Synonyms & references

Names & Synonyms

2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol2-[4-Amino-1-(Propan-2-Yl)-1h-Pyrazolo[3,4-D]pyrimidin-3-Yl]-1h-Indol-5-Ol2-(4-Amino-1-isopropyl-1H-pyrazolo(3,4-d)pyrimidin-3-yl)-1H-indol-5-ol1H-Indol-5-ol, 2-(4-amino-1-(1-methylethyl)-1H-pyrazolo(3,4-d)pyrimidin-3-yl)-1H-Indol-5-ol, 2-[4-amino-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-

Show all synonyms

2-(4-amino-1-(propan-2-yl)-1H-pyrazolo(3,4-d)pyrimidin-3-yl)-1H-indol-5-olPP242Torkinib (PP242)PP 2422-[4-Amino-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-1H-indol-5-ol2-[4-Amino-1-(1-methylethyl)-1H-pyrazolo-[3,4-d]pyrimidin-3-yl]-1H-indol-5-olTorkinib (PP242)?s2218SDCCGSBI-0654272.P002P60042-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indole-5-ol2-(4-amino-1-isopropyl-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol(2E)-2-(4-amino-1-propan-2-yl-2H-pyrazolo[3, 4-d]pyrimidin-3-ylidene)indol-5-ol2-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol, PP242

External Identifiers

DSSTOX SUBSTANCE ID: DTXSID5048685CHEMBL ID: CHEMBL1241674CHEMBL ID: CHEMBL3988893CHEBI ID: CHEBI:90679UNII: H5669VNZ7VHMDB ID: HMDB0256714NCI THESAURUS CODE: C128632WIKIDATA ID: Q27088430

Literature & Patent References

DOI 10.1021/acs.jmedchem.5c00097Chemoproteomic Profiling of <i>C. albicans</i> for Characterization of Antifungal Kinase Inhibitors.PMID 40110855Chemoproteomic Profiling of <i>C. albicans</i> for Characterization of Antifungal Kinase Inhibitors.DOI 10.1016/j.bmc.2023.117561Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors.DOI 10.1016/j.ejmech.2024.116273The mechanism of UNC-51-like kinase 1 and the applications of small molecule modulators in cancer treatment.DOI 10.6019/CHEMBL5724709EUbOPEN Chemogenomics Library - IncuCyte DOI 10.6019/CHEMBL5724796Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library PMID 38157838Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors.PMID 38432059The mechanism of UNC-51-like kinase 1 and the applications of small molecule modulators in cancer treatment.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

1We review the CAS identity, quantity, and documentation request.
2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
3We review destination and shipment documentation needs when applicable.
4We follow up with a quotation or clarification request.

Text Reference Cues

Additional text reference cues are not available for this catalog entry.

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Linked by recorded structural or research relationships, not interchangeable products. Check the exact CAS, specification and availability on the linked product page.

Structure similarity3-[(3-Methylquinoline-8-sulfonyl)amino]butanoic acidView related compound →Structure similarity4-(3-Methylquinoline-8-sulfonamido)butanoic acidView related compound →Structure similarity3-Methyl-4-(3,4,5-trimethoxybenzoyl)piperazin-2-oneView related compound →Structure similarity3-(((4-Methylthiazol-2-yl)amino)methylene)-1,5-dioxaspiro[5.5]undecane-2,4-dioneView related compound →Structure similarity2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)-N-(pyridin-2-ylmethyl)acetamideView related compound →

Procurement notes

Sourcing context and documentation notes

Show details

MolGraph uses public price and availability evidence as a starting point, then confirms current stock, quotation, COA/SDS, lot specification, lead time, and shipment documentation before final acceptance.

Package and specification

Use the quote panel for visible public options. Additional quantities or specifications can be reviewed by RFQ.

Final lot confirmation

Purity, lot identity, and batch-specific documentation are confirmed before procurement decisions.

Supply documentation

Supplier-issued COA and SDS can be requested before handling, storage, shipment, or procurement decisions.

Quotation review

Final quote depends on quantity, lead time, destination, and supplier confirmation.

Procurement questions

Is CAS 1092351-67-1 in stock?

Torkinib is in stock. Estimated delivery: 5–9 business days. Submit an RFQ to confirm final price, lot specification, documentation, and destination-specific shipping terms.

How is the final price confirmed?

The page shows a public reference price in the quote panel. Submit an RFQ to confirm current price, quantity breaks, lead time, and destination-specific shipping requirements.

Can MolGraph provide COA or SDS for CAS 1092351-67-1?

Yes. Supplier-issued COA and SDS can be requested during the RFQ workflow. Lot-specific documents depend on supplier and batch confirmation.